Hospitals Combat Pharma’s Generic Drugs: If You Can’t be ‘Em, Join ‘Em

News » Hospitals Combat Pharma's Generic Drugs: If You Can’t be ‘Em, Join ‘Em

Big Pharma's monopoly over the generic drugs industry has for years been cause for concern for U.S. hospital systems, which frequently deal with drug scarcity and manipulation of drug prices brought on by the pharmaceutical industry. Now, some hospitals are flirting with a new idea to combat the clout that pharmaceutical manufacturers and distributors hold over the rest of the healthcare industry – they want to get into the drug business themselves.

The story was first reported by the New York Times' Reed Abelson last week, and has since gained a lot of traction. The story aims to tackle the issues of inflated drug prices, as well as drug shortages, which they argue, can mostly be attributed to the nationwide lack of competition in the generic pharmaceutical drug manufacturing industry. Dr. Marc Harrison, the chief executive of Intermountain Healthcare – the nonprofit Salt Lake City-based hospital group that is spearheading this new idea – proposes that by manufacturing their own drugs, hospitals would be able to control yields based on demand, and also lower prices by cutting out the middleman.

On paper, it seems like a sound idea.

generic drugs

Dr. Harrison and Intermountain are not alone on this seemingly altruistic mission to better the healthcare industry. According to the Times, multiple hospital systems consisting of about 300 hospitals have shown interest in entering the pharma industry. Dr. Harrison explains that these hospital systems would be focusing primarily on manufacturing only a handful of generic drugs, such as heart medication, which tends to be the most problematic when it comes to scarcity and price gouging. "There are individual places where there are problems," explained Dr. Harrsion. "We are not indicating an entire industry." Rather, these hospitals want to pull their efforts to break the monopolized hold over only the most popular and most commonly prescribed generic drugs – a market that is currently dictated entirely by a small group of manufacturers who commonly manipulate market prices because there is no competition to challenge them. Dr. Harrison wants to create that competition.

The generic drugs problem is so overwhelming that federal investigations, Congressional hearings, and public outrage have so far done little to alter the market. Abelson talked to Dr. Kevin A. Schulman, a professor of medicine at Duke University who studies the generic drug market. Schulman believes that the hospitals' solution may actually be able to substantially impact the generic drug problem. "If they [the hospitals] all agree to enough to sustain this effort, you will have a huge threat to people that are trying to manipulate the generic drug market." While the hospitals' response to the generic drug problem seems theoretically sound, there are some real-world speedbumps that hospital systems will have to overcome in order to put their plan into action. One of these problems is to actually get into the generic drug market.

The Times article insinuates that the details of the hospitals' plans are very hush-hush, and for good reason. Dominant manufacturers have built a monopoly over the industry, they beat out their competition and now control prices and distribution of the entire market. If big pharma gets wind that a hospital is beginning to manufacture its own form of drug "A", big pharma simply has to drop the market price of their own drug "A" to a point where hospital competitors could not afford to enter the market – these are called "barriers to entry", and they are commonly used by monopolies to discourage competition. Even if these hospital systems are able to create subsidiary manufacturing firms and are then able to produce generic drugs under the radar of big pharma, they will still have to get FDA approval for their products. Derek Lowe of Science Magazine explains that the FDA generic drug approval process is already a logjam – "one that will not be fixed by jamming another log into it." These are just a few of the issues that hospital systems will face trying to enter the generic drug market that Lowe discusses.

Dr. Harrison and his peers seem to have come up with a plausible solution to the generic drug problem. But for their plan to succeed, they will have to come up with a conscientious way to outmaneuver big pharma. As of now, non-profit generic drugs are just pipedream. But if it were to succeed, this pipedream would have a considerable impact on the healthcare industry.

Abelson, Reed, and Katie Thomas. “Fed Up With Drug Companies, Hospitals Decide to Start Their Own.” The New York Times, The New York Times, 18 Jan. 2018, www.nytimes.com/2018/01/18/health/drug-prices-hospitals.html?rref=collection%2Fsectioncollection%2Fscience.

19, 2018 Derek LoweJanuary. “Hospitals Making Drugs?” In the Pipeline, 19 Jan. 2018, blogs.sciencemag.org/pipeline/archives/2018/01/19/hospitals-making-drugs.

Share

Related Posts

FDA Approval Process | What is the FDA Drug Approval Process?

June 23, 2020
Learn More

June 23, 2020

FDA Approval Process | What is the FDA Drug Approval Process?

Black Box Warning – The Strongest Consumer Warning FDA Can Issue

September 8, 2017
Learn More

September 8, 2017

Black Box Warning – The Strongest Consumer Warning FDA Can Issue

Generic Drugs vs. Name-Brand Drugs – How Manufacturers Dodge Liability

August 11, 2017
Learn More

August 11, 2017

Generic Drugs vs. Name-Brand Drugs – How Manufacturers Dodge Liability

Should I Report A Drug Injury or Drug Side Effect?

May 17, 2017
Learn More

May 17, 2017

Should I Report A Drug Injury or Drug Side Effect?

FAERS: A Questionable Drug Safety Reporting System

February 19, 2015
Learn More

February 19, 2015

FAERS: A Questionable Drug Safety Reporting System

FDA Approval Process Called Into Question for Unsafe Practices

August 2, 2011
Learn More

August 2, 2011

FDA Approval Process Called Into Question for Unsafe Practices

CLIENT REVIEWS

quotation
Tom Lewis

TorHoerman Law was responsible for handling a medical case for our family. I was extremely impressed with their professionalism and ability to react quickly. They also did a nice job keeping us updated with the case throughout the process. This was the first time experiencing a situation like this and Tor Hoerman law did an excellent job from start to finish.

quotation
Jordan Terry

TorHoerman Law is an extraordinary law firm – a firm that truly makes the client’s best interests the primary concern. Their team of personal injury lawyers are experienced, personable, and well versed in a range of litigation areas. They are supported by a dedicated team of staff that are as equally friendly and helpful. I would recommend TorHoerman Law for any personal injury litigation needs.

quotation
Dave Woodley

All of my questions were answered quickly and in a way I could understand. Steve and the entire staff were friendly and professional.

quotation
Jordan Butler

I highly recommend this law firm! The attorneys and staff at THL worked hard, communicated every step of the process, kept me well informed at all times, and exceeded all expectations! The staff is kind, considerate, professional, and very experienced. Look no further, call now!

quotation
Maddy Moeller

Top-notch, hardworking attorneys!

quotation
Karen Hersman

A wonderful and professional legal team. They helped me when I needed expert legal representation! Thank you TorHoerman Law!

quotation
Angel Truesdale

They contacted me the next day. Very nice people!

quotation
Paul Graegin

The firm went above and beyond. Thank you for everything.

quotation
Carie Terry

The attorneys at THL were extremely helpful with the legal aspects of setting up my small business.

THANK YOU FOR YOUR MESSAGE

One of our associates will follow up with you shortly